Abnormalities of pathways of fibrinolysis have been implicated in the pathogenesis of pleural and acute lung injury (All). The objective of this PPG is to define novel mechanisms by which urokinase plasminogen activator (uPA), its receptor (uPAR), its inhibitor (plasminogen activator inhibitor-1, PAI-1) and its product (plasmin) influence the pathogenesis of All or pleural injury. To address this, the Project Leaders of this PPG will employ a number of various in vitro, in vivo and interventional methods, which require diverse proteins with highest purity and in large quantities. The Service Core is designed to provide this service. Further, all three projects of the PPG propose to use immunohistochemistry analysis to characterize the lung injury and expression of specific proteins/markers.relevant to lung injury and its repair. The Service Core provides the provision for such expertise. Thus, the aims of the Service Core are (i) to generate and provide various fibrinolytic proteins, their variants and derivatives, in sufficient quantities and purity to support the studies described in the individual projects comprising this PPG (ii) to provide support in pathology related services, including tissue preparation, thin sectioning, analysis of immunohistochemistry and in situ hybridization studies and morphometry. The Service Core uses proven technology for large-scale expression of recombinant fibrinolytic proteins and their variants. Efficient purification methods to purify recombinant proteins have been developed by either the project leaders or consultants of the PPG. A boardcertified Anatomic Pathologist with clinical and research expertise in thoracic pathology and application and interpretation of immunohistochemistry, in situ hybridization and morphometry provides expertise, accuracy and consistency in analysis of lung specimens. Overall, the Service Core provides a valuable support to all three projects of the PPG and maximizes the resources with substantial savings in cost.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL076406-02
Application #
7312554
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
2006-09-01
Project End
2010-08-31
Budget Start
2006-09-01
Budget End
2007-08-31
Support Year
2
Fiscal Year
2006
Total Cost
$289,876
Indirect Cost
Name
University of Texas Health Center at Tyler
Department
Type
DUNS #
800772337
City
Tyler
State
TX
Country
United States
Zip Code
75708
Idell, Steven; Florova, Galina; Shetty, Sreerama et al. (2017) Precision-guided, Personalized Intrapleural Fibrinolytic Therapy for Empyema and Complicated Parapneumonic Pleural Effusions: The Case for the Fibrinolytic Potential. Clin Pulm Med 24:163-169
Hijazi, Nuha; Abu Fanne, Rami; Abramovitch, Rinat et al. (2015) Endogenous plasminogen activators mediate progressive intracerebral hemorrhage after traumatic brain injury in mice. Blood 125:2558-67
Armstead, William M; Riley, John; Cines, Douglas B et al. (2014) PAI-1-derived peptide EEIIMD prevents hypoxia/ischemia-induced aggravation of endothelin- and thromboxane-induced cerebrovasoconstriction. Neurocrit Care 20:111-8
Karandashova, Sophia; Florova, Galina; Azghani, Ali O et al. (2013) Intrapleural adenoviral delivery of human plasminogen activator inhibitor-1 exacerbates tetracycline-induced pleural injury in rabbits. Am J Respir Cell Mol Biol 48:44-52
Armstead, William M; Bohman, Leif-Erik; Riley, John et al. (2013) tPA-S(481)A prevents impairment of cerebrovascular autoregulation by endogenous tPA after traumatic brain injury by upregulating p38 MAPK and inhibiting ET-1. J Neurotrauma 30:1898-907
Marcos-Contreras, O A; Ganguly, K; Yamamoto, A et al. (2013) Clot penetration and retention by plasminogen activators promote fibrinolysis. Biochem Pharmacol 85:216-22
Armstead, William M; Riley, John; Cines, Douglas B et al. (2012) Combination therapy with glucagon and a novel plasminogen activator inhibitor-1-derived peptide enhances protection against impaired cerebrovasodilation during hypotension after traumatic brain injury through inhibition of ERK and JNK MAPK. Neurol Res 34:530-7
Armstead, William M; Ganguly, Kumkum; Riley, John et al. (2012) RBC-coupled tPA Prevents Whereas tPA Aggravates JNK MAPK-Mediated Impairment of ATP- and Ca-Sensitive K Channel-Mediated Cerebrovasodilation After Cerebral Photothrombosis. Transl Stroke Res 3:114-21
Armstead, William M; Riley, John; Yarovoi, Serge et al. (2012) tPA-S481A prevents neurotoxicity of endogenous tPA in traumatic brain injury. J Neurotrauma 29:1794-802
Tucker, Torry A; Williams, LaTerrica; Koenig, Kathleen et al. (2012) Lipoprotein receptor-related protein 1 regulates collagen 1 expression, proteolysis, and migration in human pleural mesothelial cells. Am J Respir Cell Mol Biol 46:196-206

Showing the most recent 10 out of 63 publications